Biggest News Aggregation in the World
📰 Allo News

Page 11 - Allo News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allo. Real-time updates on events, politics, business and more.

HC Wainwright Lowers Allogene Therapeutics (NASDAQ:ALLO) Price Target to $23.00

Allogene Therapeutics (NASDAQ:ALLO – Get Rating) had its price objective lowered by HC Wainwright from $29.00 to $23.00 in a research note published on Tuesday morning, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Allogene Therapeutics’ Q1 2023 earnings at ($0.61) EPS, Q2 2023 […]
United States William Blair Royal Bank Penserra Capital Management Ci Investments Inc Allogene Therapeutics Inc

MSNBC The Last Word With Lawrence ODonnell June 4, 2024 02:06:00

Elementary school. i was the same age as the thre children shot and murdered i other school in nashville, the shooting that provoked wha happened tonight in tennessee. that is what this histor making scene in tennessee an the legislature was all about. it was about the life and deat of children in america it was about those dea children and who was trying to protect the children i tennessee and who isnt. when you are in the middle o living history like this, yo owe it to yourself to stop wha you...
Elementary School Tha Legislature Idea Children Histor Making Scene American History Healt Care

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 52-Week Low Following Analyst Downgrade

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating)’s stock price reached a new 52-week low during mid-day trading on Tuesday after HC Wainwright lowered their price target on the stock from $29.00 to $23.00. The company traded as low as $4.81 and last traded at $4.82, with a volume of 412054 shares changing hands. The stock […]
Robertw Baird Ef Hutton Acquisition Co Susquehanna Fundamental Investments Jpmorgan Chase Co Allogene Therapeutics Inc Millennium Management

Allogene Therapeutics (NASDAQ:ALLO) Hits New 1-Year Low at $4.91

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) shares hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $4.91 and last traded at $4.92, with a volume of 840064 shares traded. The stock had previously closed at $5.03. Wall Street Analyst Weigh In A number of equities research […]
United States Allogene Therapeutics Company Profile Allspring Global Investments Holdings Ci Investments Inc Great West Life Assurance Co Nordwand Advisors
Source: wkrb13.com

Sanford C. Bernstein Initiates Coverage on Allogene Therapeutics (NASDAQ:ALLO)

Sanford C. Bernstein assumed coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Get Rating) in a research note issued to investors on Tuesday morning, The Fly reports. The brokerage issued a market perform rating and a $6.00 target price on the stock. Several other brokerages also recently commented on ALLO. Truist Financial cut their target […]
United States Sanfordc Bernstein Allogene Therapeutics Company Profile Allogene Therapeutics Inc Goldman Sachs Group Delphia United States Inc
Source: wkrb13.com

Allogene Therapeutics (NASDAQ:ALLO) Stock Rating Reaffirmed by William Blair

Allogene Therapeutics (NASDAQ:ALLO – Get Rating)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Wednesday, PriceTargets.com reports. Other equities research analysts have also issued reports about the company. JPMorgan Chase & Co. upgraded Allogene Therapeutics from a “neutral” rating to an “overweight” rating and reduced their […]
William Blair Great West Life Assurance Co Ci Investments Inc Penserra Capital Management Ef Hutton Acquisition Co Goldman Sachs Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science